PinnyPeptide

Cardiogen vs Vesugen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Cardiogen

Bioregulators

Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium.

Peptide B

Vesugen

Bioregulators

Khavinson short peptide bioregulator targeting vascular endothelium — KED tripeptide.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Cardiogen effects

  • Reported improvement in myocardial contractility (Russian observational)
  • Possible reduction in age-related cardiac decline
  • Improved exercise tolerance in elderly CAD patients
  • Modulation of cardiac remodeling processes
  • Anti-inflammatory effects in cardiac tissue

Vesugen effects

  • Reported improvement in endothelial function (flow-mediated dilation)
  • Reduction in arterial stiffness measures
  • Anti-inflammatory effects on vascular endothelium
  • Modulation of vascular gene expression
  • Support of nitric oxide synthesis

Cardiogen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven cardiac therapies

Vesugen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven cardiovascular therapies

Cardiogen dosing ranges

Cardiac function support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Vesugen dosing ranges

Vascular health support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Cardiogen guide → Full Vesugen guide →

Cardiogen vs Vesugen — common questions

What is the difference between Cardiogen and Vesugen?

Cardiogen: Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium. Typical dose 1,000-5,000 mcg. Vesugen: Khavinson short peptide bioregulator targeting vascular endothelium — KED tripeptide. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Cardiogen and Vesugen?

Stacking Cardiogen with Vesugen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Cardiogen or Vesugen?

Cardiogen is typically dosed: Once daily (SubQ) or sublingual for Cardiac function support. Vesugen is typically dosed: Once daily (SubQ) or sublingual for Vascular health support.

Are Cardiogen and Vesugen FDA approved?

Cardiogen: Not FDA approved. Vesugen: Not FDA approved.

Related peptide comparisons

bronchogen vs cardiogencardiogen vs cartalaxcardiogen vs cortagencardiogen vs crystagencardiogen vs ovagencardiogen vs pancragen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free